IF
ALXN

Ironwood Financial’s Alexion Pharmaceuticals ALXN Stock Holding History

Ironwood Financial’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9
Closed -$1K – 584
2020
Q4 		$1K Hold
9
– – ﹤0.01% 476
2020
Q3 		$1K Hold
9
– – ﹤0.01% 427
2020
Q2 		$1K Hold
9
– – ﹤0.01% 398
2020
Q1 		$1K Hold
9
– – ﹤0.01% 342
2019
Q4 		$1K Hold
9
– – ﹤0.01% 371
2019
Q3 		$1K Hold
9
– – ﹤0.01% 376
2019
Q2 		$1K Hold
9
– – ﹤0.01% 371
2019
Q1 		$1K Hold
9
– – ﹤0.01% 367
2018
Q4 		$1K Hold
9
– – ﹤0.01% 358
2018
Q3 		$1K Buy
+9
New +$1.13K ﹤0.01% 354
2015
Q1 		– Sell
-1
Closed – – 470
2014
Q4 		$0 Buy
+1
New +$185 ﹤0.01% 430

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ironwood Financial's ALXN Position: Q1 2021 in Review

Ironwood Financial sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 9 shares — an estimated $1K sold.

Ironwood Financial first reported a position in ALXN in Q4 2014 and held it in 11 quarters. The position peaked at $1K in Q4 2020. 754 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • Ironwood Financial reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Ironwood Financial sold 9 Alexion Pharmaceuticals shares in Q1 2021, an estimated $1K.
  • Ironwood Financial first reported a position in Alexion Pharmaceuticals in Q4 2014 and held it in 11 quarters.
  • Ironwood Financial's Alexion Pharmaceuticals position peaked at $1K in Q4 2020.
  • 754 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Ironwood Financial's 13F filing for Q1 2021, filed 28 Apr 2021.